Quarterly report pursuant to Section 13 or 15(d)

RESTATEMENT OF PRIOR FINANCIAL STATEMENTS (Details 2)

v3.22.1
RESTATEMENT OF PRIOR FINANCIAL STATEMENTS (Details 2) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Net Loss $ (1,584,339) $ (3,502,755) $ (5,648,968) $ (7,212,568)
Increase in deferred revenue - participation agreements     0  
Advanced payments for R&D obligations - participation agreements     85,303 $ 1,384,907
Amortization of Deferred R&D obligation - participation agreements     (350,099)  
As Reported [Member]        
Net Loss (1,934,438)   (5,999,067)  
Increase in deferred revenue - participation agreements     85,303  
Advanced payments for R&D obligations - participation agreements     0  
Amortization of Deferred R&D obligation - participation agreements     0  
Adjustment [Member]        
Net Loss $ 350,099   350,099  
Increase in deferred revenue - participation agreements     (85,303)  
Advanced payments for R&D obligations - participation agreements     85,303  
Amortization of Deferred R&D obligation - participation agreements     $ (350,099)